The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?
about
The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.Molecular hydrogen attenuates neuropathic pain in mice.Perceived stress and musculoskeletal pain are prevalent and significantly associated in adolescents: an epidemiological cross-sectional study.Grape pomace extract exerts antioxidant effects through an increase in GCS levels and GST activity in muscle and endothelial cells.Association between fibromyalgia syndrome and peptic ulcer disease developmentVariations in oxidative stress markers in elite basketball players at the beginning and end of a season.Relationships between human vitality and mitochondrial respiratory parameters, reactive oxygen species production and dNTP levels in peripheral blood mononuclear cells.Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats.Opioids Resistance in Chronic Pain Management.Ambroxol for the treatment of fibromyalgia: science or fiction?Pain is prevalent among adolescents and equally related to stress across genders.Identification of FAM173B as a protein methyltransferase promoting chronic pain.Application of a new oxidation-reduction potential assessment method in strenuous exercise-induced oxidative stress.Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patientsSaffron () versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
P2860
Q30575382-FDE4A90A-E0EF-4BB3-B95B-90ABED325A4DQ33774014-592D5EFC-7F10-4091-965E-22A6E7E1329DQ35820283-F21ACCCB-1B22-4F1B-B85B-79E437EC5A63Q35849894-6774BB63-5402-461E-A7AB-2931FFAB27E7Q36338568-87ECBE34-0D71-4EA8-8621-B881B144C997Q36502112-41DCA820-F83E-428F-A6ED-A7CDF44912D2Q37404941-AF5E17C6-EF3C-4A2F-B8C3-29B96CD67EB8Q38702704-6A5F8E67-32CA-420D-81C0-139CF5E38038Q39305721-5462634E-6C1F-4386-B294-7395BB3EFA75Q41483222-F10EA37D-8E4B-4183-82A5-6BCFF015328DQ47656720-D8938958-88B9-4B9A-B447-6DD4A411FDFDQ50000807-FA30C2A4-B5C4-41EC-A6F9-EFD16C2C0B11Q53665442-98382E66-1469-4CD9-8670-733EBE570ED6Q57834176-376F3861-B8CD-443E-ABC6-35A653871BCCQ59136726-A2079DE7-1127-465E-B434-2C6410D56A02
P2860
The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of mitochondrial dysf ...... anisms as therapeutic targets?
@en
type
label
The role of mitochondrial dysf ...... anisms as therapeutic targets?
@en
prefLabel
The role of mitochondrial dysf ...... anisms as therapeutic targets?
@en
P2093
P2860
P1476
The role of mitochondrial dysf ...... anisms as therapeutic targets?
@en
P2093
Dorien Goubert
Linda Hermans
Patrick Calders
P2860
P304
P356
10.1517/14728222.2013.818657
P407
P50
P577
2013-07-09T00:00:00Z